Apple Watch to Lose Blood Oxygen Feature After Patent Deal
Apple Reaches Agreement with Masimo to Remove Feature from New Models
Apple Watch are some of the most popular smartwatches on the market, and they offer a variety of health and fitness features.
However, a new patent deal with Masimo could mean that the Apple Watch will lose one of its most important health features: blood oxygen monitoring.
Patent Dispute
Masimo, a manufacturer of medical devices, sued Apple in 2022, alleging that the Apple Watch’s blood oxygen monitoring feature infringed on its patents.
Apple fought back, and the two companies eventually reached a settlement in January 2024.
Terms of the Settlement
As part of the settlement, Apple agreed to remove the blood oxygen monitoring feature from its new Apple Watch Series 9 and Watch Ultra 2 models.
The feature will remain available on existing Apple Watch models, but it is unclear how long that will be the case.
Impact on Users
The loss of the blood oxygen monitoring feature is a blow to Apple Watch users who rely on it to track their health.
Blood oxygen levels can be a valuable indicator of respiratory health, and they can also be used to monitor sleep quality.
Apple Watch users who rely on the blood oxygen monitoring feature should be aware of the change and take steps to adjust their health monitoring plans accordingly.
They should also check for updates to their Apple Watch software, as Apple may provide additional information about the change in the future.
In case you missed:
If you’d like to stay connected and receive more inspiring content, consider subscribing to ‘Afronomist’ and follow us on twitter @theafronomist. Your support is greatly appreciated, and we look forward to having you as part of our community!”
